NextPoint Therapeutics, Inc.

CIK 1959209 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NextPoint Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 30, 2026D0001959209-26-000002
Feb 14, 2024D0001959209-24-000001
Dec 27, 2022D0001959209-22-000001